REPORT ID 2922

Global Flu Vaccine Market Research Report 2017

Publish Date
12-Dec-17
Pages
107
Format
Electronic (PDF)

In this report, the global Flu Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Flu Vaccine in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Flu Vaccine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    CSL
    GSK
    Sanofi Pasteur
    Mylan
    AstraZeneca
    Pfizer
    Johnson & Johnson
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Whole Virus Vaccines
    Split Virus Vaccines
    Subunit Vaccines
    Live Attenuated Virus Vaccines
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    For Children (6 months to 3 years)
    For Adults and Children over 3 years

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Flu Vaccine Market Research Report 2017
1 Flu Vaccine Market Overview
    1.1 Product Overview and Scope of Flu Vaccine
    1.2 Flu Vaccine Segment by Type (Product Category)
        1.2.1 Global Flu Vaccine Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Flu Vaccine Production Market Share by Type (Product Category) in 2016
        1.2.3 Whole Virus Vaccines
        1.2.4 Split Virus Vaccines
        1.2.5 Subunit Vaccines
        1.2.6 Live Attenuated Virus Vaccines
    1.3 Global Flu Vaccine Segment by Application
        1.3.1 Flu Vaccine Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 For Children (6 months to 3 years)
        1.3.3 For Adults and Children over 3 years
    1.4 Global Flu Vaccine Market by Region (2012-2022)
        1.4.1 Global Flu Vaccine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Flu Vaccine (2012-2022)
        1.5.1 Global Flu Vaccine Revenue Status and Outlook (2012-2022)
        1.5.2 Global Flu Vaccine Capacity, Production Status and Outlook (2012-2022)

2 Global Flu Vaccine Market Competition by Manufacturers
    2.1 Global Flu Vaccine Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Flu Vaccine Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Flu Vaccine Production and Share by Manufacturers (2012-2017)
    2.2 Global Flu Vaccine Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Flu Vaccine Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Flu Vaccine Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Flu Vaccine Market Competitive Situation and Trends
        2.5.1 Flu Vaccine Market Concentration Rate
        2.5.2 Flu Vaccine Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Flu Vaccine Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Flu Vaccine Capacity and Market Share by Region (2012-2017)
    3.2 Global Flu Vaccine Production and Market Share by Region (2012-2017)
    3.3 Global Flu Vaccine Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Flu Vaccine Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Flu Vaccine Consumption by Region (2012-2017)
    4.2 North America Flu Vaccine Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Flu Vaccine Production, Consumption, Export, Import (2012-2017)
    4.4 China Flu Vaccine Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Flu Vaccine Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Flu Vaccine Production, Consumption, Export, Import (2012-2017)
    4.7 India Flu Vaccine Production, Consumption, Export, Import (2012-2017)

5 Global Flu Vaccine Production, Revenue (Value), Price Trend by Type
    5.1 Global Flu Vaccine Production and Market Share by Type (2012-2017)
    5.2 Global Flu Vaccine Revenue and Market Share by Type (2012-2017)
    5.3 Global Flu Vaccine Price by Type (2012-2017)
    5.4 Global Flu Vaccine Production Growth by Type (2012-2017)

6 Global Flu Vaccine Market Analysis by Application
    6.1 Global Flu Vaccine Consumption and Market Share by Application (2012-2017)
    6.2 Global Flu Vaccine Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Flu Vaccine Manufacturers Profiles/Analysis
    7.1 CSL
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Flu Vaccine Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 CSL Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 GSK
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Flu Vaccine Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 GSK Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Sanofi Pasteur
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Flu Vaccine Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Sanofi Pasteur Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Mylan
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Flu Vaccine Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Mylan Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 AstraZeneca
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Flu Vaccine Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 AstraZeneca Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Pfizer
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Flu Vaccine Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Pfizer Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Johnson & Johnson
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Flu Vaccine Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Johnson & Johnson Flu Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    ...

8 Flu Vaccine Manufacturing Cost Analysis
    8.1 Flu Vaccine Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Flu Vaccine

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Flu Vaccine Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Flu Vaccine Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Flu Vaccine Market Forecast (2017-2022)
    12.1 Global Flu Vaccine Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Flu Vaccine Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Flu Vaccine Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Flu Vaccine Price and Trend Forecast (2017-2022)
    12.2 Global Flu Vaccine Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Flu Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Flu Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Flu Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Flu Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Flu Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Flu Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Flu Vaccine Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Flu Vaccine Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer